A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

Clinical trial NCT01208181 · COMPLETED

Trial details

NCT number: NCT01208181
Sponsor: Organon and Co
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2010-09-27
Primary completion: 2014-06-09
Enrollment: 1404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.